Evidence map›Paper›PMID 35776228›Full record

ReviewCancer metastasis reviews2022

Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance.

Ridwan Islam, Juhi Mishra, Sanika Bodas, Sreyashi Bhattacharya, Surinder K Batra, Samikshan Dutta, Kaustubh Datta

Open access · bronzeAbstract readReview
In one paragraph

Review in Cancer metastasis reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. The Significance of Neuropilins in Gastrointestinal Cancers.International journal of molecular sciences · 2025
    Review
  8. MBsBMC cancer · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Neutrophil extracellular traps in homeostasis and disease.Signal transduction and targeted therapy · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ridwan Islam *Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
Juhi Mishra *Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
Sanika BodasDepartment of Molecular Genetics and Cell Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Sreyashi BhattacharyaDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
Surinder K BatraDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.
Samikshan DuttaDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA. samikshan.dutta@unmc.edu.
Kaustubh DattaDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA. kaustubh.datta@unmc.edu.
University of Nebraska Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropilins (NRPs) are transmembrane proteins involved in vascular and nervous system development by regulating angiogenesis and axon guidance cues. Several published reports have established their role in tumorigenesis. NRPs are detectable in tumor cells of several cancer types and participate in cancer progression. NRP2 is also expressed in endothelial and immune cells in the tumor microenvironment and promotes functions such as lymphangiogenesis and immune suppression important for cancer progression. In this review, we have taken a comprehensive approach to discussing various aspects of NRP2-signaling in cancer, including its regulation, functional significance in cancer progression, and how we could utilize our current knowledge to advance the studies and target NRP2 to develop effective cancer therapies.

Indexed as

NeoplasmsNeuropilin-2Signal TransductionHumansNeovascularization, PathologicNeuropilinsTumor MicroenvironmentNeuropilin-2NeuropilinsCancerNeuropilin-2NRP2SignalingTumorigenesis

Identifiers

PMID35776228
PMCPMC9247951
OpenAlexW4283770669

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.